Objective:

To provide guidance on setting realistic expectations for patients regarding gene therapy for inherited retinal diseases (IRDs), emphasizing the importance of managing these expectations.

Key Findings:

• Gene therapy represents a significant advancement in the treatment of inherited retinal diseases.
• Eligibility for gene therapy is primarily determined by genetic testing results.
• Patients often have overly optimistic expectations regarding the outcomes of gene therapy, highlighting the need for ongoing education.

Interpretation:

Accurate and balanced information about gene therapy is crucial for informed patient decision-making and managing expectations, with healthcare providers playing a key role.

Limitations:

• Patients may have misconceptions about the efficacy of gene therapy based on media portrayals.
• Eligibility criteria can be complex and vary by treatment, potentially leading to confusion.
• The emotional impact of unrealistic expectations on patients should also be considered.

Conclusion:

Effective counseling and education about gene therapy can enhance patient understanding and satisfaction with treatment options, emphasizing the importance of continuous communication.